Fertility startup Kindbody announced that it has signed a merger agreement to acquire Vios Fertility Institute, a high-growth, innovative network of fertility clinics, to increase access to patient-centric, technology-driven care across the country. The transaction doubles Kindbody’s national footprint to 26 clinics with plans to expand to 40 retail locations by year’s end.
Founded in 2018 and headquartered in New York City, Kindbody is a health and technology company providing fertility, gynecology and wellness services in modern, tech-enabled clinics. Kindbody is uniquely positioned for success in the digital healthcare sector because it provides both care navigation and care delivery with more than 64 providers across the country. The company has transformed the fertility landscape through its design-forward clinics, state-of-the-art technology and comprehensive virtual, at-home and in-person care.
Established in 2015, Vios Fertility Institute is one of the fastest growing fertility clinics in the United States with 13 locations in the Chicago, Detroit, Milwaukee, Portland and St. Louis regions. Under the leadership of global fertility leader, Dr. Angeline Beltsos, Vios has developed deep experience and proven success in clinical operations, innovation and scale.
Kindbody and Vios are both women-led companies driven by a mission and vision to revolutionize fertility care. Together, the companies performed nearly 10,000 fertility treatments in 2021 and served thousands of patients via their virtual and in-person services and is projected to double that in 2022.
Vios’ clinics, located in Illinois, Michigan, Missouri, Oregon, Washington and Wisconsin, will rebrand to Kindbody and integrate Kindbody’s proprietary patient portal, electronic medical record and telehealth platform into the expanded operations to ensure a seamless continuum of care. The announcement follows Kindbody’s expansion into at-home testing earlier this month, beginning with fertility hormone test kits for women and men.
